New diabetes clinical trial: Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes

Published on: March 28, 2019 at 06:00PM
Condition:   Type2 Diabetes
Interventions:   Drug: Entresto;   Drug: Sitagliptin;   Drug: Valsartan;   Drug: Placebo
Sponsors:   University of Copenhagen;   Hvidovre University Hospital
Recruiting